KIELY JOHN sold 19.2% of their position (50K shares) of AMNEAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $882.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/14/2026ACC: 0001628280-26-057147
-60K
Net shares
Net seller
$882.0K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
60K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−50K
Price / share
$17.64
Trade value
$882K
% of position
19.2%
8/13/2026
260.25K→210.25K
Class A Common Stock
Direct
Shares
−10K
Price / share
—
Trade value
—
% of position
4.8%
8/13/2026
210.25K→200.25K
Total
Net shares
−60K
Net value
-$882K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/13/2026 | S · Sale | −50K | $17.64 | $882K | 19.2% | 260.25K | 210.25K |
| Class A Common Stock Direct | 8/13/2026 | G · Gift | −10K | — | — | 4.8% | 210.25K | 200.25K |
| Total | −60K | -$882K | ||||||
Derivative Transactions0
No derivative transactions reported